Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations

Gut

Volumn 62, Issue 7, 2013, Pages 967-976

  Planell, Núria ^a,b   Lozano, Juan J ^b   Mora Buch, Rut ^a   Masamunt, M Carme ^a   Jimeno, Mireya ^a   Ordás, Ingrid ^a   Esteller, Miriam ^a   Ricart, Elena ^a   Piqué, Josep M ^a   Panés, Julián ^a   Salas, Azucena ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 3; AQUAPORIN 8; BETA DEFENSIN 1; BIOLOGICAL MARKER; INTERLEUKIN 8; PROTEIN REG1A; PROTEIN REG4; PROTEIN S100P; SERPINB5 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; AQUAPORIN 3 GENE; AQUAPORIN 8 GENE; ARTICLE; BETA DEFENSIN 1 GENE; CELL GROWTH; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INTERLEUKIN 8 GENE; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; MALE; MARKER GENE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REG1A GENE; REG4 GENE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; S100P GENE; SERPINB5 GENE; ULCERATIVE COLITIS;

EPITHELIAL CELLS; GENE EXPRESSION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; BIOPSY; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REMISSION INDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME; YOUNG ADULT;

EID: 84878753756     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303333     Document Type: Article

References (39)

1. Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3-11. (Pubitemid 24195339)
2. Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011;141:1194-201.
3. Ogra PL, Mestecky J, Lamm ME, et al. Mucosal immunology. San Diego; Academic Press, 1999.
4. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35. (Pubitemid 32234798)
5. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006;130:1030-8.
6. Farraye FA, Odze RD, Eaden J, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010;138:746-74, 774 e741-44; quiz e712-43.
7. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001;10:445-56. (Pubitemid 32181667)
8. Dieckgraefe BK, Stenson WF, Korzenik JR, et al. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 2000;4:1-11.
9. Noble CL, Abbas AR, Cornelius J, et al. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 2008;57:1398-405.
10. Okahara S, Arimura Y, Yabana T, et al. Inflammatory gene signature in ulcerative colitis with cDNA macroarray analysis. Aliment Pharmacol Ther 2005; 21:1091-7. (Pubitemid 40646534)
11. Costello CM, Mah N, Häsler R, et al . Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2005;2:771-87.
12. Wu F, Dassopoulos T, Cope L, et al. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007;13:807-21. (Pubitemid 47203859)
13. Bjerrum JT, Hansen M, Olsen J, et al. Genome-wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis. Inflamm Bowel Dis 2010;16 :999-1007.
14. Arijs I, De Hertogh G, Lemaire K, et al. Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment. PLoS One 2009;4:e7984.
15. Stange EF, Travis SP, Vermeire S, et al . European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis 2008;2:1-23. (Pubitemid 351179487)
16. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625-9. (Pubitemid 18010466)
17. Matts SG. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961;30:393-407.
18. Olsen J, Gerds TA, Seidelin JB, et al. Diagnosis of ulcerative colitis before onset of inflammation by multivariate modeling of genome-wide gene expression data. Inflamm Bowel Dis 2009;15:1032-8.
19. Roman J, Planell N, Lozano JJ, et al. Evaluation of responsive gene expression as a sensitive and specific biomarker in patients with ulcerative colitis. Inflamm Bowel Dis Published Online First: 12 May 2012. doi: 10.1002/ibd.23020
20. Kamarainen M, Heiskala K, Knuutila S, et al. RELP, a novel human REG-like protein with up-regulated expression in inflammatory and metaplastic gastrointestinal mucosa. Am J Pathol 2003;163:11-20. (Pubitemid 36759586)
21. Oue N, Kuniyasu H, Noguchi T, et al. Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology 2007;72:371-80. (Pubitemid 351238152)
22. Glebov OK, Rodriguez LM, Soballe P, et al. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa. Cancer Epidemiol Biomarkers Prev 2006;15:2253-62. (Pubitemid 44877053)
23. Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 2005;54:374-84. (Pubitemid 40299094)
24. Fuentes MK, Nigavekar SS, Arumugam T, et al. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum 2007;50:1230-40. (Pubitemid 47087458)
25. Lambert DW, Wood IS, Ellis A, et al. Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br J Cancer 2002;86:1262-9.
26. Rafa L, Dessein AF, Devisme L, et al. REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells. Int J Oncol 2010;36:689-98.
27. Bishnupuri KS, Luo Q, Sainathan SK, et al. Reg IV regulates normal intestinal and colorectal cancer cell susceptibility to radiation-induced apoptosis. Gastroenterology 2010;138:616-26, 626 e611-12.
28. Nanakin A, Fukui H, Fujii S, et al. Expression of the REG IV gene in ulcerative colitis. Lab Invest 2007;87:304-14. (Pubitemid 46353938)
29. Sekikawa A, Fukui H, Fujii S, et al. Possible role of REG Ialpha protein in ulcerative colitis and colitic cancer. Gut 2005;54:1437-44. (Pubitemid 41375201)
30. Brentnall TA, Pan S, Bronner MP, et al. Proteins That Underlie Neoplastic Progression of Ulcerative Colitis. Proteomics Clin Appl 2009;3:1326.
31. Zheng H, Tsuneyama K, Cheng C, et al. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res 2007;27:259-65.
32. Cao D, Wilentz RE, Abbruzzese JL, et al. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation. Int J Gastrointest Cancer 2005;36:39-46. (Pubitemid 41443608)
33. Peyrin-Biroulet L, Beisner J, Wang G, et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci USA 2010;107:8772-7.
34. De Preter V, Arijs I, Windey K, et al. Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway. Inflamm Bowel Dis 2012;18:1127-36.
35. Thibault R, De Coppet P, Daly K, et al. Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Gastroenterology 2007;133:1916-27. (Pubitemid 350180798)
36. Inan MS, Rasoulpour RJ, Yin L, et al. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 2000;118:724-34. (Pubitemid 30171622)
37. Segain JP, Raingeard de la Bletiere D, Bourreille A, et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 2000;47:397-403.
38. Siavoshian S, Segain JP, Kornprobst M, et al. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 2000;46:507-14. (Pubitemid 30305815)
39. Cuff M, Dyer J, Jones M, et al. The human colonic monocarboxylate transporter Isoform 1: its potential importance to colonic tissue homeostasis. Gastroenterology 2005;128:676-86. (Pubitemid 40585370)